| SafeShot Stops Pricks, Saves Lives - Video SafeShot Technologies Launches "No More Pricks" Campaign to Stop Deadly Needlestick Injuries & Spread of HIV and Hepatitis feedproxy.google.com |
Vivus Gets Shot Down by the FDA Zacks.com submits: Vivus Inc. (VVUS) suffered a major setback recently when the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 10-6 against the approval of Vivus’ weight loss, once-daily pill Qnexa.The FDA panel’s vote was based on one-year data on Qnexa. The panelists said that they would prefer data from a longer period of study in order to pass a favorable judgment on the drug. Data from a two-year study of Qnexa are expected to be released in the second half of 2010.Complete Story » seekingalpha.com |
Vical Incorporated. Q2 2010 Earnings Call Transcript Vical Incorporated. (VICL)Q2 2010 Earnings Call TranscriptAugust 03, 2010 12:00 pmComplete Story » seekingalpha.com |
Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy [PR Newswire] - Tengion, Inc. presented new research data yesterday in a podium presentation at the 2nd Annual Symposium on Stem Cell Translation of the International Society for Cellular Therapy in San Francisco. Â The presentation highlighted new results from Tengion's Neo-Kidney Augmentâ„¢ development program demonstrating success with an autologous cellular therapy approach to kidney regeneration in a rodent model of obesity, diabetes and hypertension. Â us.rd.yahoo.com |
BioClinica to Release Third Quarter 2010 Financial Results on November 3, 2010 [Business Wire] - BioClinica®, Inc., , a leading global provider of clinical trial management services will release its financial results for the third quarter ended September 30, 2010 on Wednesday, November 3, 2010. us.rd.yahoo.com |